• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1.

作者信息

Kitagawa Yuko, Uno Takashi, Oyama Tsuneo, Kato Ken, Kato Hiroyuki, Kawakubo Hirofumi, Kawamura Osamu, Kusano Motoyasu, Kuwano Hiroyuki, Takeuchi Hiroya, Toh Yasushi, Doki Yuichiro, Naomoto Yoshio, Nemoto Kenji, Booka Eisuke, Matsubara Hisahiro, Miyazaki Tatsuya, Muto Manabu, Yanagisawa Akio, Yoshida Masahiro

机构信息

Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Department of Radiology, Graduate School of Medicine, Chiba University, Chiba, Japan.

出版信息

Esophagus. 2019 Jan;16(1):1-24. doi: 10.1007/s10388-018-0641-9. Epub 2018 Aug 31.

DOI:10.1007/s10388-018-0641-9
PMID:30171413
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6510883/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da1/6510883/e3224e8fd08b/10388_2018_641_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da1/6510883/7ddce874e619/10388_2018_641_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da1/6510883/b138fcb19901/10388_2018_641_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da1/6510883/e3224e8fd08b/10388_2018_641_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da1/6510883/7ddce874e619/10388_2018_641_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da1/6510883/b138fcb19901/10388_2018_641_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da1/6510883/e3224e8fd08b/10388_2018_641_Fig3_HTML.jpg

相似文献

1
Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1.日本食管癌学会编辑的《2017年食管癌诊疗指南》：第1部分。
Esophagus. 2019 Jan;16(1):1-24. doi: 10.1007/s10388-018-0641-9. Epub 2018 Aug 31.
2
Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2.日本食管癌学会编辑的《2017年食管癌诊疗指南》：第2部分
Esophagus. 2019 Jan;16(1):25-43. doi: 10.1007/s10388-018-0642-8. Epub 2018 Aug 31.
3
[Esophageal carcinoma].[食管癌]
Praxis (Bern 1994). 2006 Jan 25;95(6):175-9; quiz 180. doi: 10.1024/0369-8394.95.6.175.
4
Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up.食管癌：诊断、治疗及随访临床实践指南
Ann Oncol. 2010 May;21 Suppl 5:v46-9. doi: 10.1093/annonc/mdq163.
5
Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer.内镜黏膜下剥离术/内镜下黏膜切除术治疗食管癌指南。
Dig Endosc. 2020 May;32(4):452-493. doi: 10.1111/den.13654.
6
Esophagus cancer.食管癌
Gastroenterol Clin Biol. 2006 Sep;30 Spec No 2:2S5-2S15.
7
[Present state and measures of Barrett's cancer in Japan].[日本巴雷特食管癌的现状与应对措施]
Nihon Rinsho. 2005 Aug;63(8):1470-4.
8
Endoscopic diagnosis and treatment of esophageal adenocarcinoma: introduction of Japan Esophageal Society classification of Barrett's esophagus.食管腺癌的内镜诊断和治疗：介绍日本食管学会 Barrett 食管分类。
J Gastroenterol. 2019 Jan;54(1):1-9. doi: 10.1007/s00535-018-1491-x. Epub 2018 Jun 30.
9
Prediction of esophageal stricture in patients given locoregional triamcinolone injections immediately after endoscopic submucosal dissection.预测内镜黏膜下剥离术后即刻给予局部曲安奈德注射的患者发生食管狭窄的情况。
Dig Endosc. 2018 Mar;30(2):198-205. doi: 10.1111/den.12946. Epub 2017 Sep 26.
10
Rigid Esophagoscopy for Head and Neck Cancer Staging and the Incidence of Synchronous Esophageal Malignant Neoplasms.用于头颈部癌分期的硬质食管镜检查及同步性食管恶性肿瘤的发生率
JAMA Otolaryngol Head Neck Surg. 2016 Jan;142(1):40-5. doi: 10.1001/jamaoto.2015.2815.

引用本文的文献

1
Patient background and laboratory variables associated with the efficacy of nivolumab after chemoradiotherapy in esophageal squamous cell carcinoma.与食管鳞状细胞癌放化疗后纳武单抗疗效相关的患者背景和实验室变量。
Mol Clin Oncol. 2025 Aug 7;23(4):90. doi: 10.3892/mco.2025.2885. eCollection 2025 Oct.
2
The Impact of Worsening Nutritional Status in Neoadjuvant Chemotherapy on Postoperative Outcomes in Esophageal Cancer.新辅助化疗中营养状况恶化对食管癌术后结局的影响
In Vivo. 2025 Sep-Oct;39(5):2842-2853. doi: 10.21873/invivo.14084.
3
Analysis of camrelizumab in neoadjuvant chemotherapy for esophageal cancer: A retrospective cohort study.

本文引用的文献

1
Comprehensive Registry of Esophageal Cancer in Japan, 2011.日本2011年食管癌综合登记处
Esophagus. 2018 Jul;15(3):127-152. doi: 10.1007/s10388-018-0614-z. Epub 2018 Apr 18.
2
Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for overall survival in patients with clinical Stage II/III esophageal squamous cell carcinoma (JCOG1406-A).新辅助化疗后手术与根治性放化疗对临床II/III期食管鳞状细胞癌患者总生存期的比较（JCOG1406-A）
Jpn J Clin Oncol. 2017 Jun 1;47(6):480-486. doi: 10.1093/jjco/hyx040.
3
Risk Factors for Esophageal Fistula Associated With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer: A Supplementary Analysis of JCOG0303.
卡瑞利珠单抗在食管癌新辅助化疗中的分析：一项回顾性队列研究。
Oncol Lett. 2025 Jul 17;30(4):449. doi: 10.3892/ol.2025.15195. eCollection 2025 Oct.
4
Prognostic impact of postoperative long-term skeletal muscle mass reduction after esophagectomy for esophageal cancer.食管癌食管切除术后长期骨骼肌质量减少的预后影响
Esophagus. 2025 Jul 24. doi: 10.1007/s10388-025-01145-4.
5
High expression of the cachexia-related protein Fn14 in esophageal squamous cell carcinoma correlates with poor chemotherapy response and anti-Fn14 therapy decreases chemotherapeutic resistance.恶病质相关蛋白Fn14在食管鳞状细胞癌中的高表达与化疗反应不佳相关，抗Fn14治疗可降低化疗耐药性。
Br J Cancer. 2025 Jul 15. doi: 10.1038/s41416-025-03087-1.
6
Developing a machine-learning model to enable treatment selection for neoadjuvant chemotherapy for esophageal cancer.开发一种机器学习模型，以实现食管癌新辅助化疗的治疗选择。
Sci Rep. 2025 Jul 15;15(1):25669. doi: 10.1038/s41598-025-11252-y.
7
Endoscopic Submucosal Dissection Followed by Chemoradiotherapy Versus Radiotherapy in Patients with Stage T1bN0M0 Esophageal Cancer.T1bN0M0期食管癌患者内镜下黏膜下剥离术联合放化疗与单纯放疗的比较
J Gastrointest Cancer. 2025 Jul 11;56(1):150. doi: 10.1007/s12029-025-01270-4.
8
Esophagectomy enhances hypertension remission and metabolism via weight loss in esophageal Cancer patients with hypertension.食管癌合并高血压患者进行食管切除术后，通过体重减轻可促进高血压缓解及代谢改善。
Sci Rep. 2025 Jul 2;15(1):22869. doi: 10.1038/s41598-025-06546-0.
9
Additional chemoradiotherapy following endoscopic submucosal dissection in patients with esophageal squamous cell carcinoma: a narrative review.食管鳞状细胞癌患者内镜下黏膜下剥离术后的辅助放化疗：一项叙述性综述
Front Oncol. 2025 Jun 16;15:1527634. doi: 10.3389/fonc.2025.1527634. eCollection 2025.
10
Outcomes of Older Patients Undergoing Surgery for Esophageal Squamous Cell Carcinoma.老年食管鳞状细胞癌患者手术治疗的结果
In Vivo. 2025 Jul-Aug;39(4):2286-2294. doi: 10.21873/invivo.14024.
局部晚期不可切除食管癌同步放化疗相关食管瘘的危险因素：JCOG0303补充分析
Medicine (Baltimore). 2016 May;95(20):e3699. doi: 10.1097/MD.0000000000003699.
4
Perioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus: A Phase III Randomized Trial.可切除食管鳞状细胞癌患者的围手术期与术前化疗联合手术治疗：一项 III 期随机试验。
J Thorac Oncol. 2015 Sep;10(9):1349-1356. doi: 10.1097/JTO.0000000000000612.
5
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.新辅助放化疗联合手术与单纯手术治疗食管或食管胃交界癌（CROSS）：一项随机对照临床试验的长期结果。
Lancet Oncol. 2015 Sep;16(9):1090-1098. doi: 10.1016/S1470-2045(15)00040-6. Epub 2015 Aug 5.
6
Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.食管癌和胃食管交界部癌手术后的发病率和死亡率：新辅助化疗与新辅助放化疗的随机临床试验
Eur J Surg Oncol. 2015 Jul;41(7):920-6. doi: 10.1016/j.ejso.2015.03.226. Epub 2015 Apr 8.
7
Multicenter, prospective trial of white-light imaging alone versus white-light imaging followed by magnifying endoscopy with narrow-band imaging for the real-time imaging and diagnosis of invasion depth in superficial esophageal squamous cell carcinoma.多中心前瞻性试验：单纯白光成像与白光成像后联合窄带成像放大内镜用于浅表性食管鳞状细胞癌浸润深度的实时成像与诊断
Gastrointest Endosc. 2015;81(6):1355-1361.e2. doi: 10.1016/j.gie.2014.11.015. Epub 2015 Feb 12.
8
Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303).不可切除食管鳞状细胞癌低剂量与标准剂量放化疗的随机研究（JCOG0303）
Cancer Sci. 2015 Apr;106(4):407-12. doi: 10.1111/cas.12622. Epub 2015 Mar 9.
9
Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.对于能够耐受经胸段食管癌切除术的食管鳞状细胞癌患者，比较经胸段食管癌切除术与根治性放化疗作为初始治疗方法的效果。
Ann Surg Oncol. 2015;22(6):1866-73. doi: 10.1245/s10434-014-4337-7. Epub 2015 Jan 7.
10
Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901.手术与放化疗后手术治疗Ⅰ期和Ⅱ期食管癌的比较：FFCD 9901 期随机对照Ⅲ期试验的最终分析。
J Clin Oncol. 2014 Aug 10;32(23):2416-22. doi: 10.1200/JCO.2013.53.6532. Epub 2014 Jun 30.